Personalising neurostimulation in chronic pain management: tapping into the patient experience when we can’t measure pain

The pandemic has raised awareness of the cytokine storm and exposed the potential value of diagnostic tools for assessing the host cytokine immune response. These tools could make a difference not only in COVID-19 but also in other areas of healthcare.
Ultrasound can be used to charge and power even the smallest implants that are out of reach for inductive power transmission methods. Some implant developers have adopted this approach already, but challenges remain. How will we be able to take full advantage of ultrasound to power future implants?
Developers of digital health technologies are racing to innovate and improve healthcare. But do they always know enough about the data their platform will be delivering to healthcare professionals to build a digital health solution that will be successful?
The previous wave of innovation in the contact lens market focused on wearer comfort. Will the next wave of innovation focus on usability? Charlie Constable discusses possible avenues for innovation in the contact lens market.
The trend towards greater miniaturisation offers opportunities for innovation within the implantable pulse generator (IPG) design space. It has put renewed focus on the design of the electronics and mechanical packaging. Delivering a market-leading IPG with the smallest volume requires a multi-disciplinary approach that creatively considers functionality and manufacturability across multiple domains.
In a landscape of growing competition and new distribution channels, how can branded pharmaceutical devices compete against their generic counterparts? It turns out the answer is quite simple: by leveraging the one asset a generic product doesn’t have - brand.
The use of artificial intelligence (AI) to aid medical diagnosis or rationalise healthcare raises similar ethical challenges as applications of AI in other industries, bias and discrimination among them. A prescription of selective forgetfulness for the AI may be a remedy, argue Roderick van den Bergh and Desmond Cheung.
Some very common medical conditions like migraine have evaded diagnosis and treatment until now. We explore why Machine Learning might finally be the tool to tame migraines but why it is still not an easy path to a successful product.
Antimicrobial susceptibility testing at the point of care could slow the spread of antimicrobial resistance, but only creative technology development and regulatory equivalence data will unlock this prize.
Monoclonal antibodies offer promise in the fight against a wide range of diseases, including COVID-19. The length of the discovery process is a barrier to emergency use, however, and poses a commercial risk for pharmaceutical companies. Multidisciplinary innovation could step up the pace, says Verity Jackson.